Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
EDAP
#3093
EDAP TMS SA
4.3
7
-1.80%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-1.80%
Mudança mensal
+5.56%
Mudança em 6 meses
+173.12%
Mudança anual
+65.53%
Fechamento anterior
4.4
5
Open
4.3
7
Bid
Ask
Low
4.3
7
High
4.3
7
Volume
2
Mercados
Ações
Cuidados de saúde
EDAP
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
37.39 M
144.87 M
Valuation ratios
Enterprise value
82.64 M
865.47 M
Price to earnings ratio
-4.33
169.85
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Notícias
EDAP registra receita recorde de HIFU e emite forte orientação para 2026
EDAP reports record HIFU revenue, issues strong 2026 guidance
RBOT Enters Strategic Software Partnership to Streamline Development
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO)
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
EDAP recebe aprovação da FDA para sistema robótico HIFU Focal One aprimorado
EDAP receives FDA clearance for enhanced Focal One robotic HIFU system
Preço-alvo das ações da EDAP TMS elevado para US$ 2,00 por Jefferies
EDAP TMS stock price target raised to $2.00 from $1.80 at Jefferies
Lucro da EDAP superou projeções por €0,08; receita supera estimativas
EDAP earnings beat by €0.08, revenue topped estimates